Infarto - Nursing Case Study

Pathophysiology

• Primary mechanism: Coronary artery occlusion due to atherosclerotic plaque rupture leads to reduced blood flow and oxygen supply to the myocardium, causing ischemia and subsequent myocardial cell death (infarction).

• Secondary mechanism: The ischemic cascade initiates inflammation and the release of enzymes like troponins from damaged myocardial cells, further exacerbating tissue injury and activating systemic inflammatory responses.

• Key complication: Impaired contractility and electrical instability in affected myocardial regions increase the risk of arrhythmias, heart failure, and further ischemic events, impacting overall cardiac function and patient prognosis.

Patient Profile

Demographics:

65-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia

• Current medications: Metformin, Lisinopril, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Chest pain radiating to the left arm

• Key symptoms: Shortness of breath, sweating, nausea, dizziness, palpitations

• Vital signs: Blood pressure 160/95 mmHg, Heart rate 110 bpm, Respiratory rate 24 breaths per minute, Temperature 37.2°C, Oxygen saturation 92% on room air

Section 1

As the medical team continues to monitor the patient, a change in his status becomes evident. Approximately two hours after the initial presentation, the patient begins to experience increasing shortness of breath and a sensation of heaviness in his chest. The nursing assessment reveals that his oxygen saturation has dropped further to 88% on room air, and his respiratory rate has increased to 28 breaths per minute. Auscultation indicates bilateral crackles at the lung bases, suggesting fluid accumulation due to compromised cardiac function.

A repeat set of vital signs shows a blood pressure of 150/100 mmHg and a heart rate that has escalated to 120 bpm. An electrocardiogram (ECG) is performed, revealing new-onset atrial fibrillation with a rapid ventricular response, further complicating his hemodynamic stability. Lab results show elevated troponin levels, confirming ongoing myocardial damage, and a BNP test indicates elevated levels, pointing towards potential heart failure. The patient's blood glucose is noted to be 210 mg/dL, despite his diabetes management regimen, likely exacerbated by the acute stress response.

In response to these developments, the healthcare team needs to prioritize interventions to stabilize the patient's condition. Supplemental oxygen is administered to improve his oxygen saturation, and diuretics may be considered to address pulmonary congestion. The onset of atrial fibrillation necessitates the initiation of rate control measures, possibly with beta-blockers, while carefully monitoring for hypotension given his compromised cardiac output. These interventions, along with close monitoring of cardiac rhythm and function, are critical to preventing further deterioration and guiding subsequent management decisions.

Section 2

In the hours following the initial interventions, the patient's response to the treatment is closely monitored. While supplemental oxygen slightly improves his oxygen saturation to 92%, his respiratory distress persists, and the crackles in his lung bases remain unchanged, indicating ongoing pulmonary congestion. Despite the administration of diuretics, there is minimal diuresis, suggesting a need to reassess the effectiveness and dosage of the medication. The patient's heart rate remains elevated, hovering around 115 bpm, despite the introduction of beta-blockers, which were carefully titrated to avoid hypotension. This necessitates a reevaluation of the rate control strategy, considering the balance between managing atrial fibrillation and maintaining adequate cardiac output.

Further diagnostic tests are warranted as the team considers the potential for new complications. A chest X-ray is ordered and reveals increased pulmonary vascular markings and mild cardiomegaly, reinforcing the suspicion of underlying heart failure. Laboratory results return with a further increase in troponin levels, indicating ongoing myocardial injury. The elevated BNP levels continue to suggest strain on the heart, aligning with the clinical picture of heart failure exacerbation. Additionally, the patient’s blood glucose levels remain elevated at 200 mg/dL, despite adjustments to his diabetes management plan, indicating a need for more aggressive glycemic control in the context of acute illness.

The healthcare team convenes to discuss the evolving case, recognizing the complexity of managing concurrent heart failure and atrial fibrillation in the setting of an acute myocardial infarction. The decision is made to escalate care by consulting cardiology for potential advanced interventions, such as the use of inotropic support or consideration of anti-arrhythmic therapy. The priority remains to stabilize the patient’s hemodynamics and prevent further cardiac deterioration while addressing the multifaceted challenges presented by his comorbid conditions. This approach underscores the necessity for ongoing reassessment and adaptation of the treatment strategy to guide the patient's recovery trajectory.

Section 3

As the healthcare team continues to monitor the patient, a noticeable change in his status becomes apparent. Over the next few hours, the patient begins to exhibit signs of peripheral hypoperfusion. His skin feels cool and clammy, and capillary refill time is delayed to more than three seconds. Blood pressure readings show a downward trend, dropping to 88/56 mmHg, raising concerns about potential cardiogenic shock. In response, the team initiates a low-dose inotropic infusion to support cardiac output and improve tissue perfusion, all while carefully balancing the risk of exacerbating his myocardial oxygen demand.

Additionally, the patient's respiratory status further deteriorates. He becomes progressively more tachypneic, with a respiratory rate climbing to 28 breaths per minute, and he experiences increasing difficulty in maintaining adequate oxygenation. Repeat arterial blood gas analysis reveals worsening hypoxemia with a PaO2 of 60 mmHg and rising PaCO2 levels, which indicates impending respiratory failure. This development prompts the team to consider non-invasive positive pressure ventilation to assist breathing and reduce the work of the heart.

These changes necessitate an urgent reassessment of the patient's overall management plan. The cardiology consultant suggests revisiting the need for coronary intervention to address potential ongoing ischemia contributing to his hemodynamic instability. Meanwhile, the critical care team discusses the possibility of transferring the patient to the intensive care unit for closer monitoring and advanced support options. This decision-making process highlights the need for a dynamic and integrative approach, ensuring that each aspect of the patient's complex condition is addressed while adapting to evolving clinical challenges.

Section 4

As the team deliberates the patient's management plan, new diagnostic results provide further insight into his deteriorating condition. A repeat echocardiogram reveals significant left ventricular dysfunction, with an ejection fraction reduced to 30%, confirming severe systolic heart failure. This finding correlates with the patient's declining hemodynamic status and supports the suspicion of ongoing myocardial ischemia. Additionally, serum lactate levels have risen to 4 mmol/L, indicating worsening tissue hypoperfusion and increasing anaerobic metabolism. Troponin levels continue to trend upwards, suggesting persistent myocardial injury.

In response to these findings, the healthcare team escalates the patient's care. They initiate a higher dose of inotropic support to enhance cardiac contractility while carefully monitoring for any signs of increased myocardial oxygen consumption that could exacerbate ischemia. The decision is made to proceed with urgent coronary angiography to identify and potentially revascularize any critical coronary artery lesions. The team acknowledges the delicate balance required in optimizing cardiac output without overwhelming the compromised myocardium.

Despite these interventions, the patient begins to exhibit new complications. He develops acute pulmonary edema, evidenced by bilateral crackles on auscultation and a chest X-ray showing diffuse alveolar infiltrates. This progression highlights the need for aggressive diuretic therapy and further respiratory support. The patient is transferred to the intensive care unit for closer monitoring and potential escalation to invasive mechanical ventilation if non-invasive measures prove insufficient. This transition underscores the evolving complexity of his condition and the necessity for a comprehensive, multi-disciplinary approach to stabilize his status and prevent further deterioration.

Section 5

As the patient settles into the intensive care unit, the team conducts a comprehensive initial assessment to establish a baseline for ongoing management. The patient is in significant respiratory distress, exhibiting tachypnea with a respiratory rate of 30 breaths per minute, and he is using accessory muscles to breathe. Oxygen saturation has dropped to 86% on high-flow nasal cannula, indicating severe hypoxemia. His heart rate is elevated at 120 beats per minute, and blood pressure is precariously low at 85/55 mmHg, reflecting persistent cardiogenic shock. Auscultation of the lungs reveals coarse crackles throughout all lung fields, consistent with worsening pulmonary congestion.

In light of these findings, the team decides to intensify diuretic therapy, administering intravenous furosemide to rapidly decrease fluid overload. Simultaneously, they adjust the inotropic support to maintain adequate perfusion pressure while avoiding excessive myocardial oxygen demand. A decision is made to initiate non-invasive positive pressure ventilation to improve oxygenation and reduce the work of breathing. Blood gas analysis shows a pH of 7.28, PaCO2 of 52 mmHg, and PaO2 of 55 mmHg, confirming a mixed respiratory and metabolic acidosis due to hypoventilation and lactic acidosis.

Despite these interventions, the patient's status remains tenuous. His urine output decreases to 15 mL/hour, raising concern for acute kidney injury secondary to low perfusion and diuretic therapy. The clinical team recognizes the need for careful titration of diuretics and consideration of renal protective strategies, such as adjusting inotropic agents or considering renal replacement therapy if necessary. These developments necessitate an interdisciplinary discussion to align on a strategy that balances cardiac support with renal function preservation, ensuring a holistic approach to the patient's rapidly evolving condition.